|
In order to view this program you must log in. If you do not have an account, please register for one.
Viewing the webcast requires use of the free RealPlayer. 
If you are having problems viewing the program, please check out our technical support section.
|
| Credits | 1.00 |
| Release Date | 1/9/2009 |
| Termination Date | 1/9/2012 |
| Cost |
$25.00 to view the program and complete a post test for CME credit. To purchase this program please log in.
|
| Description | According to the American Academy of Family Physicians, The goal of anticoagulant therapy is to administer the lowest possible dose of anticoagulant to prevent clot formation or expansion. The required degree of anticoagulation continues to evolve as studies provide more information about the efficacy and safety of lower doses.
This activity is supported in part by educational grants from Merck and Astellas. |
| Accreditation Statement | The Ohio State University Medical Center, Center for Continuing Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The Ohio State University Medical Center designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. |
| Author | Mark Wurster, MD and Melissa Snider, PharmD |
| Objectives | Upon completion of this educational activity, the participant should be able to: 1.) Review anticoagulation therapy, with emphasis on improving quality of care. 2.) Discuss appropriate use of warfarin, heparin, LMWH by means of case presentations and examples. 3.) Explain how to appropriately monitor warfarin therapy. 4.) Identify when to recommend bridge therapy for interruption in warfarin therapy.
|
| Audience | This course is designed for physicians. |
| Estimated Time to Complete | 1 Hour |
